- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-435/22: Action brought on 12 July 2022 — Pascoe pharmazeutische Präparate v EUIPO — Novartis Pharma (PASCELMO)
ECLI:EU:UNKNOWN:62022TN0435
62022TN0435
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
29.8.2022
EN
Official Journal of the European Union
C 326/28
(Case T-435/22)
(2022/C 326/38)
Language in which the application was lodged: English
Parties
Applicant: Pascoe pharmazeutische Präparate GmbH (Gießen, Germany) (represented by: M. Kinkeldey, S. Brandstätter and S. Clotten, lawyers)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Novartis Pharma AG (Basel, Switzerland)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Other party to the proceedings before the Board of Appeal
Trade mark at issue: International registration designating the European Union in respect of the word mark PASCELMO — International registration designating the European Union No 1 516 387
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 4 May 2022 in Case R 1890/2021-2
Form of order sought
The applicant claims that the Court should:
—annul the contested decision;
—order that the costs of the proceedings be borne by the defendant and by the other party to the proceedings before the Board of Appeal if it joins as intervener.
Pleas in law
—Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;
—Infringement of Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.